20 articles
A dual-action therapy combining a glucose-responsive hydrogel with stem cell exosomes dramatically speeds diabetic wound closure in mice.
Researchers explore targeted immune strategies to improve pancreatic islet transplant success rates for diabetes treatment.
Researchers shift from systemic B-cell targeting to localized immune control, potentially improving transplant success rates.
Electromagnetic biomaterials offer breakthrough approach to diabetic wound healing by reducing inflammation and promoting tissue regeneration.
UC Riverside scientists developed a gel that delivers continuous oxygen to chronic wounds, healing fatal injuries in diabetic mice within weeks.
New research reveals how blood vessel maturity around transplanted insulin-producing cells determines long-term survival.
A comprehensive 2025 review maps the metabolic chaos driving diabetic foot ulcers and evaluates emerging treatments from exosomes to gene therapy.
Scientists discover signaling pathways that could enhance insulin-producing cells and improve diabetes treatment outcomes.
Three NIH-funded studies this week tackle metabolic decline, cardiac risk, and brain tumors — all with aging implications.
Three new NIH-funded findings tackle metabolic aging, cardiovascular risk, and a surprising hormonal brake on brain tumors.
Scientists identify how different immune cells use specific nutrient transporters, revealing new targets for autoimmune diseases.
Researchers found a dual-target approach that selectively destroys the most treatment-resistant form of acute myeloid leukemia.
A landmark JCI review maps the expanding pharmacological arsenal for MASH, from GLP-1 agonists to triple receptor therapies and precision medicine.
Comprehensive therapy combining Western medicine, traditional Chinese medicine, and lifestyle changes reversed diabetes in majority of patients.
New research reveals pulsed electromagnetic field therapy selectively enhances ATP-linked mitochondrial respiration, pointing to a specific cellular energy mechanism.
New research identifies LRG1 protein as early trigger of diabetic retinopathy, opening door to prevention-based treatments.
A 2025 mini-review synthesizes RCTs and meta-analyses showing hypertonic dextrose prolotherapy rivals or beats standard OA injections.
Breakthrough modulator therapies are changing how doctors diagnose and treat diabetes in cystic fibrosis patients worldwide.
New research reveals how mitochondrial metabolism regulates dendritic cells' ability to activate anti-tumor immunity.
New research reveals how SREBP2 protein triggers liver fibrosis through metabolic changes, offering hope for treating liver disease.
